MRCP
MRCP most commonly refers to magnetic resonance cholangiopancreatography, a noninvasive imaging test that uses magnetic resonance imaging to visualize the biliary tree and pancreatic ducts. MRCP relies on heavily T2-weighted MRI sequences to produce high-contrast images of static fluids, often without intravenous contrast. It is used to diagnose biliary obstruction and pancreatic ductal disease, including choledocholithiasis, bile duct strictures, pancreatic ductal anomalies, cystic lesions, and congenital abnormalities. MRCP is noninvasive and does not involve ionizing radiation and can serve as a diagnostic alternative to endoscopic retrograde cholangiopancreatography (ERCP) when therapeutic intervention is not required. Variants include secretin-enhanced MRCP, which can improve duct visualization by stimulating pancreatic secretions, and contrast-enhanced MRCP in some protocols. Limitations include reduced sensitivity for very small stones or complex ductal anatomy, limited ability to assess surrounding tissues or perform therapy, and contraindications to MR imaging such as certain implants, severe claustrophobia, or unstable renal function in protocols requiring gadolinium.
MRCP also stands for Membership of the Royal College of Physicians, commonly the MRCP(UK). It is a